Skip to main content
. Author manuscript; available in PMC: 2020 May 28.
Published in final edited form as: N Engl J Med. 2019 Nov 28;381(22):2103–2113. doi: 10.1056/NEJMoa1905795

Figure 2. Posterior Probabilities of Success According to Treatment Group for the Primary Outcome of Cessation of Status Epilepticus at 60 Minutes.

Figure 2.

The relative posterior probabilities of treatment success with regard to the primary outcome for each drug are shown. The percentage of patients with treatment success was 47% (95% credible interval, 39 to 55) in the levetiracetam group, 45% (95% credible interval, 36 to 54) in the fosphenytoin group, and 46% (95% credible interval, 38 to 55) in the valproate group.